Tag: bladder cancer treatment

Bristol Myers Squibb announces Opdivo FDA approval for urothelial carcinoma

In a significant stride toward enhancing bladder cancer treatment, Bristol Myers Squibb (NYSE: BMY) announced the U.S. Food and Drug Administration (FDA) approval of Opdivo ... Read More